|
OMIM |
Link |
Information gain |
01 |
|
CF
|
[NCBI]
|
0.00130677
|
|
|
PDR
|
[NCBI]
|
0.000866698
|
|
|
NCR
|
[NCBI]
|
0.000866698
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000866698
|
|
|
TNF
|
[NCBI]
|
0.000813657
|
|
|
DIP
|
[NCBI]
|
0.000693453
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.000613493
|
|
|
schinzel-giedion midface-retraction syndrome
|
[NCBI]
|
0.000570168
|
|
|
MPO
|
[NCBI]
|
0.000271806
|
|
|
ADA
|
[NCBI]
|
0.000192242
|
|
|
UGB
|
[NCBI]
|
0.000169174
|
|
|
CVID
|
[NCBI]
|
0.000142599
|
|
|
lymphoid system deterioration, progressive
|
[NCBI]
|
0.000103679
|
|
|
CCR6
|
[NCBI]
|
9.58404e-05
|
|
|
HMGB1
|
[NCBI]
|
9.01268e-05
|
|
|
SLPI
|
[NCBI]
|
6.5461e-05
|
|
|
MBL2
|
[NCBI]
|
5.99252e-05
|
|
|
EHBA
|
[NCBI]
|
5.73035e-05
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
5.73035e-05
|
|
|
CGD
|
[NCBI]
|
5.68207e-05
|
|
|
DEF6
|
[NCBI]
|
5.08349e-05
|
|
|
LRMP
|
[NCBI]
|
5.08349e-05
|
|
|
TLR4
|
[NCBI]
|
4.58511e-05
|
|
|
TNFRSF4
|
[NCBI]
|
4.56483e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
4.5632e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
4.34456e-05
|
|
|
MARCO
|
[NCBI]
|
3.97887e-05
|
|
|
BPI
|
[NCBI]
|
3.97887e-05
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
3.9047e-05
|
|
|
RUNX3
|
[NCBI]
|
3.7802e-05
|
|
|
CPM
|
[NCBI]
|
3.7802e-05
|
|
|
XCL1
|
[NCBI]
|
3.7802e-05
|
|
|
HAS2
|
[NCBI]
|
3.7802e-05
|
|
|
HSS
|
[NCBI]
|
3.69137e-05
|
|
|
EGF
|
[NCBI]
|
3.63399e-05
|
|
|
NFE2L2
|
[NCBI]
|
3.61524e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
3.50467e-05
|
|
|
TFF2
|
[NCBI]
|
3.47424e-05
|
|
|
THBS1
|
[NCBI]
|
3.47424e-05
|
|
|
SCDO1
|
[NCBI]
|
3.18998e-05
|
|
|
IL17A
|
[NCBI]
|
3.14388e-05
|
|
|
PFIC1
|
[NCBI]
|
3.09857e-05
|
|
|
MIF
|
[NCBI]
|
3.05488e-05
|
|
|
MYD88
|
[NCBI]
|
3.05488e-05
|
|
|
RCDP1
|
[NCBI]
|
3.01261e-05
|
|
|
SLE
|
[NCBI]
|
3.0083e-05
|
|
|
SFTPC
|
[NCBI]
|
2.97344e-05
|
|
|
MC2R
|
[NCBI]
|
2.97344e-05
|
|
|
SHH
|
[NCBI]
|
2.89975e-05
|
|
|
HMOX1
|
[NCBI]
|
2.89839e-05
|
|
|
TLR2
|
[NCBI]
|
2.82926e-05
|
|
|
CYP2D6
|
[NCBI]
|
2.76399e-05
|
|
|
IGKC
|
[NCBI]
|
2.70332e-05
|
|
|
AD
|
[NCBI]
|
2.66027e-05
|
|
|
PI3
|
[NCBI]
|
2.5417e-05
|
|
|
EGFR
|
[NCBI]
|
2.47802e-05
|
|
|
TLR5
|
[NCBI]
|
2.32222e-05
|
|
|
CFTR
|
[NCBI]
|
2.17597e-05
|
|
|
IL13
|
[NCBI]
|
2.05326e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.01708e-05
|
|
|
RNASE3
|
[NCBI]
|
1.82341e-05
|
|
|
wolman disease
|
[NCBI]
|
1.77989e-05
|
|
|
MMP2
|
[NCBI]
|
1.73819e-05
|
|
|
PRL
|
[NCBI]
|
1.69245e-05
|
|
|
STAT6
|
[NCBI]
|
1.6792e-05
|
|
|
PCNA
|
[NCBI]
|
1.61078e-05
|
|
|
REG3A
|
[NCBI]
|
1.55564e-05
|
|
|
CCL17
|
[NCBI]
|
1.43374e-05
|
|
|
HP
|
[NCBI]
|
1.35495e-05
|
|
|
FRDA
|
[NCBI]
|
1.34722e-05
|
|
|
EPO
|
[NCBI]
|
1.19114e-05
|
|
|
VEGF
|
[NCBI]
|
1.10086e-05
|
|
|
GFAP
|
[NCBI]
|
1.09709e-05
|
|
|
HPS
|
[NCBI]
|
1.0001e-05
|
|
|
PCD
|
[NCBI]
|
8.82612e-06
|
|
|
AGER
|
[NCBI]
|
8.17857e-06
|
|
|
PLG
|
[NCBI]
|
7.37495e-06
|
|
|
CHS
|
[NCBI]
|
6.94149e-06
|
|
|
VIP
|
[NCBI]
|
6.52e-06
|
|
|
OSM
|
[NCBI]
|
6.3855e-06
|
|
|
GJA1
|
[NCBI]
|
6.25072e-06
|
|
|
CEACAM5
|
[NCBI]
|
6.06279e-06
|
|
|
CYP1A1
|
[NCBI]
|
4.99157e-06
|
|
|
RTT
|
[NCBI]
|
4.68474e-06
|
|
|
FGF7
|
[NCBI]
|
4.22149e-06
|
|
|
CRH
|
[NCBI]
|
4.0306e-06
|
|
|
NGFB
|
[NCBI]
|
3.01629e-06
|
|
|
ACE
|
[NCBI]
|
2.92051e-06
|
|
|
TH
|
[NCBI]
|
2.74643e-06
|
|
|
GIST
|
[NCBI]
|
2.70428e-06
|
|
|
AT
|
[NCBI]
|
2.37955e-06
|
|
|
CAT
|
[NCBI]
|
1.83876e-06
|
|
|
APOE
|
[NCBI]
|
1.72523e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.25587e-06
|
|
|
FRAP1
|
[NCBI]
|
1.17522e-06
|
|
|
PD
|
[NCBI]
|
1.13418e-06
|
|
|
TFPI
|
[NCBI]
|
1.0737e-06
|
|
|
XDH
|
[NCBI]
|
9.96971e-07
|
|
|
HGF
|
[NCBI]
|
9.65299e-07
|
|
|
RA
|
[NCBI]
|
9.37479e-07
|
|
|
AVP
|
[NCBI]
|
2.38024e-07
|
|
|
VDR
|
[NCBI]
|
1.56716e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.75083e-09
|
|
|
HD
|
[NCBI]
|
6.79331e-10
|
|